My bookmarksSign up free

Commission Implementing Regulation (EU) No 406/2013 of 2 May 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance prednisolone Text with EEA relevance

Commission Implementing Regulation (EU) No 406/2013 of 2 May 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance prednisolone Text with EEA relevance

Implementing Regulation (EU) No 406/2013 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 3 July 2013.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry corresponding to prednisolone is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification ‘Prednisolone Prednisolone Bovine 4  μg/kg Muscle NO ENTRY Corticoids/Glucocorticoids’ 4  μg/kg Fat 10  μg/kg Liver 10  μg/kg Kidney 6  μg/kg Milk Equidae 4  μg/kg Muscle 8  μg/kg Fat 6  μg/kg Liver 15  μg/kg Kidney

Other acts of the same type
Commission Implementing Regulation (EU) 2026/1311 of 15 June 2026 amending Implementing Regulation (EU) 2025/807 as regards administrative and minor changes to the Union authorisation of the biocidal product C(M)IT/MIT & Glutaraldehyde FormulationsCommission Regulation (EU) 2026/1314 of 15 June 2026 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 1,4-dimethylnaphthalene, chlormequat, metribuzin, metribuzin-desamino-diketo (metribuzin-DADK), terbuthylazine and triclopyr in or on certain productsCommission Implementing Regulation (EU) 2026/1315 of 15 June 2026 setting out the content and practical arrangements for the quality reports and metadata pursuant to Regulation (EU) 2025/941 of the European Parliament and of the CouncilCouncil Regulation (EU) 2026/1336 of 15 June 2026 amending Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Implementing Regulation (EU) 2026/1353 of 15 June 2026 amending Implementing Regulations (EU) 2020/617 and (EU) No 540/2011 as regards the conditions of approval of the active substance metalaxyl-MCouncil Implementing Regulation (EU) 2026/1356 of 15 June 2026 implementing Regulation (EU) 2024/2642 concerning restrictive measures in view of Russia’s destabilising activitiesCouncil Implementing Regulation (EU) 2026/1358 of 15 June 2026 implementing Regulation (EU) 2023/888 concerning restrictive measures in view of actions destabilising the Republic of MoldovaCouncil Implementing Regulation (EU) 2026/1361 of 15 June 2026 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCouncil Implementing Regulation (EU) 2026/1362 of 15 June 2026 implementing Regulation (EU) 2024/1485 concerning restrictive measures in view of the situation in RussiaCommission Implementing Regulation (EU) 2026/1280 of 12 June 2026 fixing the adjustment rate for direct payments pursuant to Regulation (EU) 2021/2116 of the European Parliament and of the Council in respect of the calendar year 2026Commission Implementing Regulation (EU) 2026/1288 of 12 June 2026 on the stand-alone suspension of the trading obligation for derivatives in accordance with Regulation (EU) No 600/2014 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/1291 of 12 June 2026 laying down implementing technical standards for the application of Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to the format of insider lists, and repealing Commission Implementing Regulation (EU) 2022/1210

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next